select a format

Single User License
USD 125 INR 8115
Site License
USD 250 INR 16230
Corporate User License
USD 375 INR 24345

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Wockhardt Ltd (WOCKPHARMA)-Financial and Strategic SWOT Analysis Review

Wockhardt Ltd (WOCKPHARMA)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH34240FSA
  • |
  • Pages: 45
  • |
  • August 2017
  • |
  • |
  Request for Sample Report

Executive Summary

Wockhardt Ltd (WOCKPHARMA)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Wockhardt Ltd (Wockhardt) is a pharmaceutical company that manufactures and markets vaccines, active pharmaceutical ingredients, pharmaceutical and recombinant bio-pharmaceutical formulations. The company's product portfolio caters to various therapeutic areas including orthopedics, dental care, dermatology, rheumatology, gynecology, pediatrics, cardiology, pain management, nephrology, neurology and diabetes, among others. Wockhardt holds expertise in biotechnology research with a focus on gene cloning; and development of production strains and expression of proteins. It also concentrates its research in generics, novel drug delivery system; and new chemical entities. The company has presence in India, the UK, Switzerland and British Virgin Islands. Wockhardt is headquartered in Mumbai, Maharashtra, India.

Wockhardt Ltd Key Recent Developments

Jun 22,2017: Wockhardt and its Subsidiaries settle with Teva and its Affiliate a commercial litigation in the High Court, London

May 29,2017: WOCKPHARMA Announces Update on Aurangabad facility

May 04,2017: Wockhardt Q4FY17 Net Sales at Rs.864 crore and FY16-17 at Rs. 4,015 crore

Mar 07,2017: WOCKPHARMA Provides Update on Aurangabad facility

Jan 24,2017: Wockhardt Q3FY17 Net Sales at Rs.995 crore, EBITDA at Rs. 18 cr

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Wockhardt Ltd-Key Facts 5

Wockhardt Ltd-Key Employees 6

Wockhardt Ltd-Key Employee Biographies 7

Wockhardt Ltd-Major Products and Services 8

Wockhardt Ltd-History 10

Wockhardt Ltd-Locations And Subsidiaries 11

Head Office 11

Other Locations & Subsidiaries 11

Section 2-Company Analysis 13

Wockhardt Ltd-Business Description 13

Wockhardt Ltd-SWOT Analysis 14

SWOT Analysis-Overview 14

Wockhardt Ltd-Strengths 14

Wockhardt Ltd-Weaknesses 15

Wockhardt Ltd-Opportunities 16

Wockhardt Ltd-Threats 17

Wockhardt Ltd-Key Competitors 18

Section 3-Company Financial Ratios 19

Financial Ratios-Capital Market Ratios 19

Financial Ratios-Annual Ratios 20

Performance Chart 23

Financial Performance 23

Financial Ratios-Interim Ratios 24

Financial Ratios-Ratio Charts 25

Section 4-Company's Lifesciences Financial Deals and Alliances 26

Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26

Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27

Wockhardt Ltd, Recent Deals Summary 28

Section 5-Company's Recent Developments 29

Jun 22, 2017: Wockhardt and its Subsidiaries settle with Teva and its Affiliate a commercial litigation in the High Court, London 29

May 29, 2017: WOCKPHARMA Announces Update on Aurangabad facility 30

May 04, 2017: Wockhardt Q4FY17 Net Sales at Rs.864 crore and FY16-17 at Rs. 4,015 crore 31

Mar 07, 2017: WOCKPHARMA Provides Update on Aurangabad facility 33

Jan 24, 2017: Wockhardt Q3FY17 Net Sales at Rs.995 crore, EBITDA at Rs. 18 cr 34

Jan 05, 2017: Wockhardt Provides Update On Its Manufacturing Facility Ankaleshwar, Gujarat 35

Dec 19, 2016: Wockhardt Provides Update On Its Manufacturing Unit At Chikalthana, Aurangabad 36

Dec 13, 2016: Wockhardt Provides Update On Its Manufacturing Unit At Kadaiya, Daman 37

Nov 23, 2016: Wockhardt: USFDA Warning Letter to CP Pharmaceuticals 38

Nov 10, 2016: Wockhardt Q2FY17 Net Sales at Rs.1,065 crore, EBITDA at Rs. 100 crore, grew by 18% Quarter on Quarter 39

Section 6-Appendix 41

Methodology 41

Ratio Definitions 41

About GlobalData 45

Contact Us 45

Disclaimer 45

List of Figures

Wockhardt Ltd, Performance Chart (2013-2017) 23

Wockhardt Ltd, Ratio Charts 25

Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26

Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 27

List of Tables

Wockhardt Ltd, Key Facts 5

Wockhardt Ltd, Key Employees 6

Wockhardt Ltd, Key Employee Biographies 7

Wockhardt Ltd, Major Products and Services 8

Wockhardt Ltd, History 10

Wockhardt Ltd, Other Locations 11

Wockhardt Ltd, Subsidiaries 11

Wockhardt Ltd, Key Competitors 18

Wockhardt Ltd, Ratios based on current share price 19

Wockhardt Ltd, Annual Ratios 20

Wockhardt Ltd, Annual Ratios (Cont...1) 21

Wockhardt Ltd, Annual Ratios (Cont...2) 22

Wockhardt Ltd, Interim Ratios 24

Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26

Wockhardt Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27

Wockhardt Ltd, Recent Deals Summary 28

Currency Codes 41

Capital Market Ratios 41

Equity Ratios 42

Profitability Ratios 42

Cost Ratios 43

Liquidity Ratios 43

Leverage Ratios 44

Efficiency Ratios 44

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Wockhardt Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com